SGLT2 & GLP-1 in Diabetes
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists. The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.
Hide..
Show more..
Screenshots
User Rating
0 out of 5
0 ratings in New Zealand
Ratings History
Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
VAD Care
|
0
|
3 years ago | |
Diabetes Clinical Care
|
0
|
10 years ago | |
Metabolic Diseases
|
0
|
1 month ago | |
Radrite: CDSM for PAMA
Qualified PAMA CDSM by CMS
|
0
|
2 years ago | |
NIH: Diabetes Glossary
|
0
|
3 years ago | |
Iron Book
Track weightlifting focused
|
0
|
4 years ago | |
CME CASES
|
0
|
2 years ago | |
N/A/
N/A/
|
0
|
10 months ago | |
Kabyier - Doctor
KabyierDoc – Manage Patients
|
0
|
1 year ago | |
Linus Administrator
Clinical Cognitive Assessments
|
0
|
4 weeks ago |
Show More
Revenue and Downloads
Gain valuable insights into SGLT2 & GLP-1 in Diabetes performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- UMA MLG, LLC
- Languages
- English
- Recent version
- 1.0.4 (4 years ago )
- Released on
- Oct 4, 2019 (4 years ago )
- Also available in
- Canada, Switzerland, Spain, New Zealand, Taiwan, United States, South Africa, Brazil, Colombia, United Kingdom, Hungary, Japan
- Last updated
- 1 month ago